Acuity Eye Group is a
Ophthalmology based in Pasadena, California. Acuity Eye Group is licensed to practice in California (license number A69909) and their current practice location is
100 E California Blvd, Pasadena, California. It can be reached at their office (for appointments etc.) via phone at
(626) 568-8838.
NPI number for Acuity Eye Group is 1194185694 and their current mailing address is 288 N Santa Anita Ave Ste 402, Arcadia, California. Acuity Eye Group
does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1194185694.
Healthcare Provider's Profile
Full Name | Acuity Eye Group |
---|
Type | Facility |
---|
Speciality | Ophthalmology |
---|
Location | 100 E California Blvd, Pasadena, California |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
NPI Data:
- NPI Number: 1194185694
- Provider Enumeration Date: 02/26/2016
- Last Update Date: 02/03/2023
Medical Identifiers
Medical identifiers for Acuity Eye Group such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1194185694 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
152W00000X | Optometrist | A69909 (California) | Secondary |
207W00000X | Ophthalmology | A69909 (California) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Acuity Eye Group is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Acuity Eye Group 288 N Santa Anita Ave Ste 402, Arcadia, CA 91006-3183 Ph: (800) 898-2020 | Acuity Eye Group 100 E California Blvd, Pasadena, CA 91105 Ph: (626) 568-8838 |
Reviews and Comments